Cadrenal Therapeutics, Inc. Common Stock(CVKD)

Biotechnology · Ponte Vedra, FL

$0.94-0.01 (-1.13%)

Delayed quote: Oct 6, 2026, 11:30 AM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T15:32:35.273Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:32:35.273Z.

Quote observation: 2026-10-06T15:30:56.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 3,336,054
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 2,388,135
TTM operating EBITDA · period ending 2026-06-30: -11,651,672

FMP input reference: e7a9a1b17caad0ab37430e79e816a911291535ac0fb348029df9f580b63ef335

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

CVKD EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

CVKD Competitors' EV/EBITDA Ratio

CVKD

Cadrenal Therapeutics, Inc. Common Stock

Current

Market Cap

$3.34M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AEMD

Aethlon Medical, Inc.

vs CVKD

Market Cap

$3.35M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ICCM

IceCure Medical Ltd

vs CVKD

Market Cap

$3.27M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MLEC

Moolec Science S.A.

vs CVKD

Market Cap

$3.40M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PAVS

Paranovus Entertainment Technology Ltd.

vs CVKD

Market Cap

$3.25M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EOCN

Eocene Ltd.

vs CVKD

Market Cap

$3.46M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MBAI

MBody AI Ltd.

vs CVKD

Market Cap

$3.21M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MBIO

Mustang Bio, Inc.

vs CVKD

Market Cap

$3.49M

EV/EBITDA Ratio

N/A

TTM Avg

1128.55x

3Y Avg

1128.55x

5Y Avg

1128.55x

EVGN

Evogene Ltd.

vs CVKD

Market Cap

$3.50M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NXL

Nexalin Technology, Inc.

vs CVKD

Market Cap

$3.55M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Cadrenal Therapeutics, Inc. Common Stock (CVKD)	$3.34M	N/A	N/A	N/A	N/A
Aethlon Medical, Inc. (AEMD)vs ›	$3.35M	N/A	N/A	N/A	N/A
IceCure Medical Ltd (ICCM)vs ›	$3.27M	N/A	N/A	N/A	N/A
Moolec Science S.A. (MLEC)vs ›	$3.40M	N/A	N/A	N/A	N/A
Paranovus Entertainment Technology Ltd. (PAVS)vs ›	$3.25M	N/A	N/A	N/A	N/A
Eocene Ltd. (EOCN)vs ›	$3.46M	N/A	N/A	N/A	N/A
MBody AI Ltd. (MBAI)vs ›	$3.21M	N/A	N/A	N/A	N/A
Mustang Bio, Inc. (MBIO)vs ›	$3.49M	N/A	1128.55x	1128.55x	1128.55x
Evogene Ltd. (EVGN)vs ›	$3.50M	N/A	N/A	N/A	N/A
Nexalin Technology, Inc. (NXL)vs ›	$3.55M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics